R. Kowalczyk et al. / Tetrahedron: Asymmetry 19 (2008) 2310–2315
2313
(ESI, [M+H]+) calcd for [C36H58N2O2+H]+ 551.4571; found
551.4579.
L
-tartrate salt (1.0 equiv) in water (46 mL/10 mmol of salt) at rt.
Then ethanol (96%, 20 mL/10 mmol of salt) was added, followed
by solution of an aldehyde (2.0 equiv) and CH3SO3H (0.1 mL) in
dichloromethane. The biphasic mixture was stirred at rt overnight,
refluxed for 2 h, and concentrated in vacuo to evaporate organic
solvents. After cooling, ethyl acetate was added (50 mL), the phases
were separated, and the water layer was washed with AcOEt
(3 ꢁ 50 mL). Combined organic layers were dried over Na2SO4
and solvent was evaporated in vacuo giving a crude diimine, which
was directly used in the next step.
The diimine was dissolved in MeOH (5 mL/10 mmol). In the
case of non-soluble compounds, toluene was added to dissolution.
The resulting mixture was cooled on an ice-bath, and NaBH4
(2.5 equiv) was added in one portion. Stirring at this temperature
was maintained until gas evaporation was stopped, and then the
mixture was allowed to reach rt and then refluxed for 2 h. The sol-
vents were removed in vacuo and the residue was treated with
water (50 mL/10 mmol of salt) and dichloromethane (50 mL/
10 mmol of salt). Phases were separated, and the upper layer was
washed with CH2Cl2. The combined organic fractions were dried
over K2CO3, and the solvent was evaporated in vacuo. The product
was purified by column chromatography on silica gel (50 g/
10 mmol of salt, gradient CHCl3 to CHCl3/MeOH, 10:1, v/v) giving
the desired product.
4.2.4. Compound 1i
Ligand 1i was prepared according to the general procedure
starting from (1R,2R)-(+)-1,2-diaminocyclohexane L-tartrate salt
(1.52 g, 5.75 mmol). Part of the imine (536 mg, 1.49 mmol) was
reduced to afford 511 mg (93% yield after two stages) of the
desired product as a light yellow oil, Rf = 0.40 (CHCl3/EtOH, 20:1,
v/v), ½a D
ꢂ
¼ ꢃ62:0 (c 0.5, MeOH); IR (film): mmax 3296, 3065, 2928,
2855, 1572, 1445, 1126, 1038, 1049, 751 cmꢃ1
;
1H NMR d 7.39
(dd, J = 7.2 Hz, 2.0 Hz, 2H, ArH), 7.30 (dd, J = 7.2, 2.0 Hz, 2H, ArH),
7.12–7.22 (m, 4H, ArH), 3.95 (d, J = 13.8 Hz, 2H, CHAHB), 3.74 (d,
J = 13.8 Hz, 2H, CHAHB), 2.23–2.27 (m, 2H, 2 ꢁ CHN), 2.16 (br d,
J = 13.2 Hz, 2H, CH2), 2.02 (br s, 2H, 2 ꢁ NH), 1.70–1.73 (m, 2H,
CH2), 1.19–1.26 (m, 2H, CH2), 1.03–1.10 (m, 2H, CH2). 13C NMR d
138.5 (CAr IV°), 133.8 (CAr IV°), 130.0 (CAr), 129.4 (CAr), 128.1
(CAr), 126.8 (CAr), 61.1 (CHN), 48.4 (CHAHB), 31.7 (CH2), 25.1
+
(CH2). HRMS (ESI, [M+H]+) calcd for [C20H24N2Cl2+H] 363.1389;
found 363.1374.
4.2.5. Compound 1j
Ligand 1j was prepared according to the general procedure
starting from (1R,2R)-(+)-1,2-diaminocyclohexane L-tartrate salt
(1.32 g, 5.0 mmol). Part of the imine (500 mg, 1.39 mmol) was
reduced to afford 494 mg (92% yield) of the desired product as a
light yellow solid, mp = 53–55 °C; Rf = 0.36 (CHCl3/EtOH, 20:1,
4.2.2. Compound 1c
Ligand 1c was prepared according to the general procedure
starting from (1R,2R)-(+)-1,2-diaminocyclohexane L-tartrate salt
(500 mg, 1.9 mmol). The crude imine (628 mg) was reduced to
afford 399 mg (54% yield after two stages) of the desired product
as a light yellow solid, mp = 74–76 °C; Rf = 0.31 (CHCl3/EtOH,
v/v), ½a D
ꢂ
¼ ꢃ53 (c 0.5, MeOH); IR (film): mmax 3301, 3062, 2928,
2855, 1597, 1575, 1458, 1200, 1117, 868, 778, 683 cmꢃ1
;
1H
NMR d 7.30 (s, 2H, ArH), 7.16–7.25 (m, 6H, ArH), 3.85 (d,
J = 13.5 Hz, 2H, CHAHB), 3.61 (d, J = 13.5 Hz, 2H, CHAHB), 2.20–2.23
(m, 2H, 2 ꢁ CHN), 2.09–2.14 (m, 2H, CH2), 1.85 (br s, 2H, 2 ꢁ NH),
1.69–1.73 (m, 2H, CH2), 1.18–1.24 (m, 2H, CH2), 0.99–1.06 (m,
2H, CH2); 13C NMR d 143.3 (CAr IV°), 134.2 (CAr IV°), 129.7 (CAr),
128.1 (CAr), 127.0 (CAr), 126.2 (CAr), 61.0 (CHN), 50.4 (CHAHB),
31.7 (CH2), 25.1 (CH2). HRMS (ESI, [M+H]+) calcd for
[C20H24N2Cl2+H]+ 363.1389; found 363.1389.
20:1, v/v), ½a D
ꢂ
¼ þ15:9 (c 0.4, MeOH); IR (film): mmax 3297, 3051,
2925, 2856, 1599, 1508, 1450, 1126, 855, 813, 744, 473 cmꢃ1
;
1H
NMR d 7.74–7.83 (m, 8H, ArH), 7.41–7.49 (m, 6H, ArH), 4.08 (d,
J = 13.2 Hz, 2H, CHAHB), 3.83 (d, J = 13.2 Hz, 2H, CHAHB), 2.32–
2.35 (m, 2H, 2 ꢁ CHN), 2.21 (br d, J = 11.4 Hz, 2H, CH2), 2.02 (s,
2H, 2 ꢁ NH), 1.73–1.76 (m, 2H, CH2), 1.22–1.28 (m, 2H, CH2),
1.06–1.09 (m, 2H, CH2). 13C NMR d 139.0 (CAr IV°), 133.8 (CAr IV°),
132.9 (CAr IV°), 128.2 (CAr), 128.0 (CAr), 127.9 (CAr), 127.0 (CAr),
126.5 (CAr), 126.2(CAr), 125.7 (CAr), 61.2 (CHN), 51.2 (CHAHB), 31.9
(CH2), 25.4 (CH2). HRMS (ESI, [M+H]+) calcd for [C28H30N2+H]+
395.2482; found 395.2466.
4.2.6. Compound 1k
Ligand 1k was prepared according to the general procedure
starting from (1R,2R)-(+)-1,2-diaminocyclohexane L-tartrate salt
(778 mg, 2.95 mmol). Imine (1.014 g, 2.82 mmol) was reduced
affording 884 mg (83% after two stages) of the desired product as
4.2.3. Compound 1g
a light yellow oil, Rf = 0.32 (CHCl3/EtOH, 20:1, v/v), ½a D
(c 0.5, MeOH); IR (film): mmax 3299, 3027, 2928, 2854, 1597,
1490, 1457, 1091, 1015, 800 cmꢃ1 1H NMR d 7.22 (AB system,
ꢂ ¼ ꢃ46:2
(1R,2R)-Diaminocyclohexane (71 mg, 0.62 mmol, 1.0 equiv) in
toluene (2.0 mL) was added to the solution of the aldehyde
(293 mg, 1.25 mmol, 2.0 equiv) in toluene (4.0 mL), followed by
anhydrous MgSO4 (3.0 g). The resulting solution was stirred vigor-
ously for 24 h at rt, heated at reflux for 1 h, and then cooled. The
solid was filtered, and washed with toluene (2 ꢁ 10 mL). The fil-
trate was concentrated in vacuo, dried under high vacuum giving
320 mg of crude oily imine. The reduction was performed follow-
ing the general procedure affording 190 mg (55% yield after two
;
J = 14.6, 8.6 Hz, 8H, ArH), 3.83 (d, J = 13.3 Hz, 2H, CHAHB), 3.59 (d,
J = 13.3 Hz, 2H, CHAHB), 2.18–2.21 (m, 2H, 2 ꢁ CHN), 2.11 (br d,
J = 13.2 Hz, 2H, CH2), 1.84 (s, 2H, 2 ꢁ NH), 1.69–1.71 (m, 2H, CH2),
1.16–1.23 (m, 2H, CH2), 0.98–1.01 (m, 2H, CH2); 13C NMR d 139.7
(CAr IV°), 132.5 (CAr IV°), 129.4 (CAr), 128.5 (CAr), 60.9 (CHN), 50.2
(CHAHB), 31.6 (CH2), 25.1 (CH2). HRMS (ESI, [M+H]+) calcd for
[C20H24N2Cl2+H]+ 363.1389; found 363.1371.
stages) of
¼ ꢃ33:0 (c 0.2, MeOH); IR (film): mmax 3312, 2927, 2855,
1601, 1493, 1455, 1242, 1106, 751 cmꢃ1 1H NMR d 7.22 (dd,
a colorless oil; Rf = 0.72 (CHCl3/EtOH, 20:1, v/v),
½aꢂD
4.2.7. Compound 1l
;
Diamine 1l was prepared by the reduction of the corresponding
diimine.16
J = 7.2, 1.5 Hz, 2H, ArH), 7.16 (dt, J = 7.9, 1.5 Hz, 2H, ArH), 6.85
(t, J = 7.2 Hz, 2H, ArH), 6.77 (d, J = 7.9 Hz, 2H, ArH), 3.83–3.93
(m, 6H, 2 ꢁ CH2O + CHAHB), 3.61 (d, J = 13.2 Hz, 2H, CHAHB), 2.50
(br s, 2H, 2 ꢁ NH), 2.21–2.24 (m, 2H, 2 ꢁ CHN), 2.13 (br d,
J = 12.6 Hz, 2H, CH2), 1.65–1.70 (m, 6H, 3 ꢁ CH2), 1.18–1.37 (m,
22H, 11 ꢁ CH2), 1.03–1.06 (m, 2H, CH2), 0.87 (t, J = 6.6 Hz, 6H,
2 ꢁ CH3); 13C NMR d 157.1 (CAr IV°), 129.7 (CAr), 129.0 (CAr IV°),
127.9 (CAr), 120.1 (CAr), 110.9 (CAr), 67.9 (CH2O), 60.7 (CHN),
46.1 (CHAHB), 31.9 (CH2), 31.4 (CH2), 29.44 (CH2), 29.37 (CH2),
29.36 (CH2), 26.2 (CH2), 25.1 (CH2), 22.7 (CH2), 14.2 (CH3). HRMS
The diimine (428 mg, 1.0 mmol, 1.0 equiv) was suspended in
MeOH (5.0 mL) after which NaBH4 (190 mg, 5.0 mmol, 5.0 equiv)
was added portionwise for 10 min at rt, which caused gas libera-
tion. After 24 h, water was added (10 mL), the resulting mixture
was stirred for 5 min and the solvents were evaporated in vacuo.
The residue was treated with CH2Cl2 (10 mL) and brine (10 mL),
phases were separated and water layer was washed with CH2Cl2
(5 ꢁ 5 mL). Combined organic fractions were dried (K2CO3), and
solvent was evaporated giving 379 mg (88% yield) of white